TABLE 2.

Characteristics of the Women Who Were Eligible for BRCA1/2 Genetic Testing by Their Genetic Testing Intention (N = 100)

	Genetic Testing Intention
	Yes (N = 76)		No (N = 24)
Characteristic	$\overline{\mathbf{X}}$	SD	$\overline{\mathbf{X}}$	SD	p
Age (years)	58.74	10.88	66.71	12.72	0.007
CES-D score	15.39	12.47	8.13	7.79	0.009
GAD-7 score	5.63	6.23	1.46	2.25	0.004
Six-Point Scale score	9.13	4.92	7.58	3.68	0.266
Characteristic		n		n	p
Education					0.014
High school or less		50		9
More than high school		26		15
Race/ethnicity					0.031
Hispanic		60		13
Non-Hispanic White		7		8
Non-Hispanic Black		6		2
Asian/other		3		1
Age at first live birth (years)					0.312
No live births		8		6
Younger than 20		24		4
20–24		22		6
25–29		16		5
30 or older		6		3
Menopausal status					0.291
Pre- or perimenopausal		17		2
Postmenopausal		59		22
First-degree relatives who had breast cancera					0.101
1 or more		42		9
0		32		15
Blood relatives tested positive for breast cancer gene mutation					0.061
Yes		11		1
No		43		20
Do not know		22		3
Breast cancer risk perceptionb					0.599
Much higher		26		8
About the same		30		12
Much lower		19		4
CES-D scorec					0.009
High (clinically significant)		32		3
Low (not clinically significant)		40		21
GAD-7 score					0.004
No anxiety		43		21
Mild anxiety		14		3
Moderate anxiety		10		0
Severe anxiety		9		0

^a2 missing responses in the yes group

^b1 missing response in the yes group

^c4 missing responses in the yes group

CES-D—Center for Epidemiologic Studies Depression Scale; GAD-7—Generalized Anxiety Disorder–7

Note. Missing data are because some participants chose not to respond.

Note. Total scores on the CES-D range from 0–60. A score of 16 or higher was used as the cut-off point for clinically significant depressive symptoms. Total scores on the GAD-7 range from 0–21. Scores of 5–9 indicate mild anxiety, 10–14 moderate anxiety, and 15–21 severe anxiety. Scores greater than 6 on the Six-Point Scale warrant referral for genetic testing.